Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP980616.RAWL0RY70Dhy68vP3j-zIHpR9Fdr1JTbtc4eHqN2okPhM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP980616.RAWL0RY70Dhy68vP3j-zIHpR9Fdr1JTbtc4eHqN2okPhM130_assertion type Assertion NP980616.RAWL0RY70Dhy68vP3j-zIHpR9Fdr1JTbtc4eHqN2okPhM130_head.
- NP980616.RAWL0RY70Dhy68vP3j-zIHpR9Fdr1JTbtc4eHqN2okPhM130_assertion description "[NSCLC specimens that harbored activating EGFR mutations were more likely to express low ERCC1 and TS mRNA levels, whereas patients with NSCLC who had ALK rearrangement were more likely to express low TS mRNA levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980616.RAWL0RY70Dhy68vP3j-zIHpR9Fdr1JTbtc4eHqN2okPhM130_provenance.
- NP980616.RAWL0RY70Dhy68vP3j-zIHpR9Fdr1JTbtc4eHqN2okPhM130_assertion evidence source_evidence_literature NP980616.RAWL0RY70Dhy68vP3j-zIHpR9Fdr1JTbtc4eHqN2okPhM130_provenance.
- NP980616.RAWL0RY70Dhy68vP3j-zIHpR9Fdr1JTbtc4eHqN2okPhM130_assertion SIO_000772 22569898 NP980616.RAWL0RY70Dhy68vP3j-zIHpR9Fdr1JTbtc4eHqN2okPhM130_provenance.
- NP980616.RAWL0RY70Dhy68vP3j-zIHpR9Fdr1JTbtc4eHqN2okPhM130_assertion wasDerivedFrom befree-2016 NP980616.RAWL0RY70Dhy68vP3j-zIHpR9Fdr1JTbtc4eHqN2okPhM130_provenance.
- NP980616.RAWL0RY70Dhy68vP3j-zIHpR9Fdr1JTbtc4eHqN2okPhM130_assertion wasGeneratedBy ECO_0000203 NP980616.RAWL0RY70Dhy68vP3j-zIHpR9Fdr1JTbtc4eHqN2okPhM130_provenance.